DK3071192T3 - Curcuphenolforbindelse til anvendelse i behandling af cancer - Google Patents
Curcuphenolforbindelse til anvendelse i behandling af cancer Download PDFInfo
- Publication number
- DK3071192T3 DK3071192T3 DK14815145.9T DK14815145T DK3071192T3 DK 3071192 T3 DK3071192 T3 DK 3071192T3 DK 14815145 T DK14815145 T DK 14815145T DK 3071192 T3 DK3071192 T3 DK 3071192T3
- Authority
- DK
- Denmark
- Prior art keywords
- cancer treatment
- curcuphenol compound
- curcuphenol
- compound
- cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361906817P | 2013-11-20 | 2013-11-20 | |
| PCT/US2014/066543 WO2015077411A1 (en) | 2013-11-20 | 2014-11-20 | Curcuphenol compounds for increasing mhc-i expression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3071192T3 true DK3071192T3 (da) | 2020-03-16 |
Family
ID=52117996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14815145.9T DK3071192T3 (da) | 2013-11-20 | 2014-11-20 | Curcuphenolforbindelse til anvendelse i behandling af cancer |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US20150147314A1 (da) |
| EP (2) | EP3071192B1 (da) |
| JP (4) | JP6560215B2 (da) |
| CN (1) | CN106456572A (da) |
| CA (1) | CA2930156C (da) |
| DK (1) | DK3071192T3 (da) |
| ES (1) | ES2775577T3 (da) |
| HU (1) | HUE049301T2 (da) |
| PL (1) | PL3071192T3 (da) |
| WO (1) | WO2015077411A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2930156C (en) | 2013-11-20 | 2023-11-07 | Biommune Technologies Inc. | Curcuphenol compounds for increasing mhc-i expression |
| CA2993183A1 (en) * | 2015-07-22 | 2017-01-26 | Teva Pharmaceuticals International Gmbh | Pridopidine base formulations and their use |
| KR102901722B1 (ko) * | 2018-12-17 | 2025-12-17 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 치환된 헤테로사이클 융합 감마-카르볼린 합성 |
| EP3917904A4 (en) * | 2019-01-31 | 2022-11-16 | Cava Healthcare Inc. | COMPOUNDS TO INCREASE MHC-I EXPRESSION AND MODULATE HISTONE DEACETYLASE ACTIVITY |
| TW202214244A (zh) * | 2020-08-10 | 2022-04-16 | 國立彰化師範大學 | 具有協同抗癌功效之氯硝柳胺（Ｎｉｃｌｏｓａｍｉｄｅ）和雙硫侖（Ｄｉｓｕｌｆｉｒａｍ）醫藥組合物及其用途 |
| EP4255576A4 (en) * | 2020-12-07 | 2024-10-23 | The Trustees of Indiana University | METHODS FOR SENSITIZING CANCER CELLS TO IMMUNE ATTACK USING ATRACTYLENOLIDE I |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6261939A (ja) * | 1985-09-10 | 1987-03-18 | Yamanouchi Pharmaceut Co Ltd | クルクフエノ−ル誘導体及びこれを含有する医薬 |
| KR100439425B1 (ko) * | 2001-03-22 | 2004-07-05 | (주)바이오케어 | 잔토리졸을 포함하는 조성물 및 그 용도 |
| CN1842326A (zh) * | 2003-06-24 | 2006-10-04 | 生物关怀有限公司 | 癌症化疗药物所引起的毒性的抑制剂以及含有该抑制剂的癌症化疗药物组合物 |
| CA2688570A1 (en) * | 2007-05-31 | 2008-12-04 | F.P.L. Pharma Inc. | Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof |
| CA2930156C (en) | 2013-11-20 | 2023-11-07 | Biommune Technologies Inc. | Curcuphenol compounds for increasing mhc-i expression |
-
2014
- 2014-11-20 CA CA2930156A patent/CA2930156C/en active Active
- 2014-11-20 JP JP2016533609A patent/JP6560215B2/ja active Active
- 2014-11-20 EP EP14815145.9A patent/EP3071192B1/en active Active
- 2014-11-20 ES ES14815145T patent/ES2775577T3/es active Active
- 2014-11-20 DK DK14815145.9T patent/DK3071192T3/da active
- 2014-11-20 HU HUE14815145A patent/HUE049301T2/hu unknown
- 2014-11-20 US US14/548,726 patent/US20150147314A1/en not_active Abandoned
- 2014-11-20 PL PL14815145T patent/PL3071192T3/pl unknown
- 2014-11-20 CN CN201480072728.3A patent/CN106456572A/zh active Pending
- 2014-11-20 EP EP19216024.0A patent/EP3639815A1/en not_active Withdrawn
- 2014-11-20 WO PCT/US2014/066543 patent/WO2015077411A1/en not_active Ceased
-
2017
- 2017-01-25 US US15/415,291 patent/US10751296B2/en active Active
-
2019
- 2019-07-18 JP JP2019132434A patent/JP2019196380A/ja not_active Withdrawn
-
2020
- 2020-08-20 US US16/998,072 patent/US11197832B2/en not_active Expired - Fee Related
-
2021
- 2021-04-06 JP JP2021064761A patent/JP7071570B2/ja not_active Expired - Fee Related
- 2021-11-08 US US17/521,674 patent/US12011421B2/en active Active
-
2022
- 2022-05-09 JP JP2022076869A patent/JP2022093724A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US10751296B2 (en) | 2020-08-25 |
| JP2016539129A (ja) | 2016-12-15 |
| WO2015077411A1 (en) | 2015-05-28 |
| EP3071192B1 (en) | 2019-12-18 |
| US20150147314A1 (en) | 2015-05-28 |
| US12011421B2 (en) | 2024-06-18 |
| CN106456572A (zh) | 2017-02-22 |
| EP3071192A1 (en) | 2016-09-28 |
| US20170319508A1 (en) | 2017-11-09 |
| US20200375917A1 (en) | 2020-12-03 |
| JP2022093724A (ja) | 2022-06-23 |
| PL3071192T3 (pl) | 2020-06-29 |
| JP2021100982A (ja) | 2021-07-08 |
| CA2930156A1 (en) | 2015-05-28 |
| HUE049301T2 (hu) | 2020-09-28 |
| CA2930156C (en) | 2023-11-07 |
| JP7071570B2 (ja) | 2022-05-19 |
| JP2019196380A (ja) | 2019-11-14 |
| EP3639815A1 (en) | 2020-04-22 |
| ES2775577T3 (es) | 2020-07-27 |
| JP6560215B2 (ja) | 2019-08-14 |
| US11197832B2 (en) | 2021-12-14 |
| US20220062195A1 (en) | 2022-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL280908B (en) | Combination therapy with neoantigen vaccine | |
| DK3076976T3 (da) | Fremgangsmåder til behandling af cancer | |
| DK3060237T3 (da) | Modificeret omprogrammeringsprotein til anvendelse i behandling af cancer | |
| HUE057061T2 (hu) | Kombinációs terápia rák kezelésére | |
| DK2897620T3 (da) | Fremgangsmåde til behandling af cancer | |
| DK3030323T3 (da) | Kdm1a-inhibitorer til behandlingen af sygdom | |
| DK3046583T3 (da) | Viruslignende partikelkonjugater til behandling af tumorer | |
| EP2990700A4 (en) | SLIDING PART | |
| LT3060041T (lt) | Prostaciklino junginiai | |
| DK2970336T3 (da) | Tetrahydropyrrolothiazinforbindelser | |
| EP2989885A4 (en) | HARVESTER | |
| DK2994533T3 (da) | Fremgangsmåder og sammensætninger til behandling af cancer | |
| BR302013003403S1 (pt) | Configuração aplicada em bolsa | |
| DK3027750T3 (da) | Biokatalytisk sammensætning | |
| DK3089749T3 (da) | Kombinerede præparater til behandling af cancer | |
| EP2982331A4 (en) | Treatment tool | |
| LT3563837T (lt) | Terapija bakteriofagu | |
| LT2981303T (lt) | Užpildo kompozicija lipoatrofijos gydymui | |
| DK3052102T3 (da) | Sammensætninger til behandling af cancere | |
| IL240499A0 (en) | Caix stratification based cancer treatment | |
| IL240904A0 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| DK3016682T3 (da) | Metoder til behandling af kræft | |
| DK3071192T3 (da) | Curcuphenolforbindelse til anvendelse i behandling af cancer | |
| DK2964248T3 (da) | Behandling af og profylakse for stråledermatitis | |
| HRP20180618T1 (hr) | Spojevi fluorfenilpirazola |